Yew Bio Pharm Balance Sheet - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.28 $0 (0.36%) YEWB stock closing price Oct 27, 2016 (Closing)

The financial analysis of a company like Yew Bio Pharm involves checking the three financial statements of the company in detail, of which the balance sheet is one. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Yew Bio Pharm stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Yew Bio Pharm revenue was $16.06M and Yew Bio Pharm operating cash flow was $0.22M for 2016-Q2. The balance sheet shows total liabilities of $4.77M and shareholders equity of $40.79M. View Yew Bio Pharm quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
Get Balance sheet for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Marketable Securities----------
Raw Materials0.68M4.28M3.33M2.39M2.57M1.91M1.44M1.64M0.78M1.45M
Work In Progress---------0.01M
Finished Goods7.97M5.48M1.33M5.39M0.93M0.78M-0.08M0.08M0.1M
Notes Receivable----------
Other Current Assets0.18M1.27M0.17M0.64M2.13M0.03M0.02M0.04M0.04M0.01M
Yew Bio Pharm Total Current Assets
Property Plant & Equipment--1.74M---1.89M---
Accumulated Depreciation--1.04M---1.03M---
Yew Bio Pharm Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets14.5M11.51M12.33M11.39M11.08M10.86M10.66M10.55M10.01M10M
Yew Bio Pharm Total Assets
Notes Payable0.6M---------
Accounts Payable0.11M0.11M0.05M2.22M0.42M1.21M-0.01M0.04M-
Current Portion Long-Term Debt3.76M3.83M3.84M2.33M2.33M0.04M0.04M0.29M1.04M3.4M
Current Portion Capital Leases----------
Accrued Expenses0.28M0.1M0.12M0.17M0.26M0.13M0.08M0.12M0.13M0.15M
Income Taxes Payable0.01M0.02M0.01M0.04M0.01M0.04M0.01M-0.01M-
Other Current Liabilities---0.16M0.06M-----
Yew Bio Pharm Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Yew Bio Pharm Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Capital Surplus9.78M9.7M9.62M9.36M9.1M8.86M8.55M8.38M8.05M8.05M
Retained Earnings27.15M25.99M25.06M23.84M23.04M21.26M20.44M19.92M19.16M17.89M
Treasury Stock----------
Other Liabilities3.8M4.82M4.42M5.02M6.59M6.23M5.84M5.75M5.61M5.42M
Yew Bio Pharm Shareholders Equity
Yew Bio Pharm Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Yew Bio Pharm stock price, and Yew Bio Pharm historical stock prices show the stock price movement over time, and the Yew Bio Pharm PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: Anything that the Yew Bio Pharm company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Yew Bio Pharm had total assets of $45.56M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Yew Bio Pharm is $4.77M. Shareholders' equity comes under liabilities as it is money the company owes the holders of YEWB stock.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio

Quarterly Balance Sheets For Yew Bio-Pharm Group, Inc. Peers

Fibria Celulose balance sheet, Grow Solutions balance sheet, Pope Resources balance sheet